Bliss GVS Pharma: Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | Value Research

Bliss GVS Pharma: Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held on September 15 2022 has approved the allotment of 76 750 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 (Bliss GVS ESOP-2019).

Click here to view PDF


Other Categories